Roquefort Therapeutics plc (LON:ROQ)

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2021
Biotechnology	200.00K	Log In
Biotechnology Growth	27716.41%	Log In

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2021
United Kingdom, Europe and Australia	200.00K	Log In
United Kingdom, Europe and Australia Growth	27716.41%	Log In